13
Total investments
3
Early stage
3
Mid stage
3
Late stage
12y
Years active
Portfolio
13 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2024
Hi! We’re Aavia, a daily app that helps you track & understand how your hormones impact your life. Ovarian hormones impact everything from quality of sleep and risk of injury to mood and sex drive. Our unique design and experience provides members with insights, predictions, and education into their hormone cycles to feel better, and supports doctors to provide more efficient care to reach faster diagnosis of hormone conditions.
Aavia was founded at MIT by a customer-obsessed MBA, an award-winning product designer, and a patent-owning electrical engineer, all energized by their mission to change the way that the world understands ovarian hormones thanks to their personal experiences. What began with our patented Smart Birth Control Pill Case evolved into an all-in-one app for hormone health insights for all people with ovaries.
We are backed by some of the most innovative consumer and health tech investors, founders, and advisors including 776, Asset Management Ventures, and more. Together, we are building a world-class product to impact the ovarian hormone health of generations to come.
Learn more on www.aavia.io, the Aavia app (available on iOS), Instagram @aavia.io, Twitter @aavia_io, and TikTok!
Investor
Apr 2024
Axiom Space is a human space exploration company, building era-defining space infrastructure and delivering technology-driven solutions that will empower civilization to transcend Earth. Beginning with Axiom Station, successor to the International Space Station, the company is pioneering a next-generation orbital settlement that will foster groundbreaking innovation and research in microgravity and drive the global space economy of tomorrow. Today, guided by the vision of leading humanitys expansion off planet, Axiom Space is the principal provider of commercial human spaceflight services and developer of advanced spacesuits for the Moon and beyond.
Connect with us:
instagram.com/axiom.space/
twitter.com/axiom_space
facebook.com/axiomspace/
youtube.com/axiomspace
Investor
Mar 2024
We are a team of engineers, scientists and doctors working at the intersection of AI, Physics and Biology to make the Star Trek MedBay a reality.
Investor Accelerator Venture Fellow
May 2023
Dream VC is a Pan-African venture capital institute. Dream VC creates and delivers educational programs focused on investment capacity building, particularly in venture capital, angel investing, and corporate venture capital (CVC).
To date, Dream VC has successfully run multiple programs with participants from over 50 different countries. Our programs are highly selective with a ~4 % acceptance rate. We are powered by a network of 300+ fellow alumni who have started, currently lead or work at Venture Capital, Private Equity and Impact Funds, collectively managing nearly $7bn in AUM.
Venture Investor
Feb 2023
Kabisa is a Rwanda-based electric mobility company. Kabisa offers services that build out the electric vehicle ecosystem in East Africa including the selling and leasing of electric vehicles, a public charging network build out and operation, and an electric vehicle maintenance service.
Venture Investor
Sep 2022
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From licensing our platforms, to working with us as a trusted discovery service partner, we have collaborated with over 170+ partners and counting including 18 of Fortune 50 Biopharmaceutical companies to enable the discovery of their next breakthrough biologic medicines.
With Alloy, you can:
• Access our ever-growing stable of antibody and bispecific discovery platforms that blend in vivo and in vitro wet-lab capabilities with AI/ML. Discover with us through our services or by licensing our technologies for use in your lab.
• Unlock intracellular targets with the therapeutic potential of T cell receptor (TCR) modalities through our fully integrated Keyway™ TCRm discovery service offering.
• Reach genetic disease targets at the nucleic acid level with our novel AntiClastic™ ASO Format, which enhances the molecules potency while minimizing off-target interaction and inflammatory response.
• Co-build new biotechnology companies that leverage our core platforms and service capabilities with Alloys affiliated Venture Studio, 82VS.
Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Boston, MA, with labs in Cambridge, U.K.; Basel, CH; and Athens, GA. We reinvest 100% of our revenue back into innovation and access to innovation.
Reach out, follow, and visit our website, to learn more about how we can make better medicines, together.
https://www.alloytx.com/
VC Investor
Jun 2020
Imperative is the tool that gives employees the time and space to build meaningful relationships at work. We combine AI technology and behavioral science to manage, scale, and measure connections across companies that bust silos, ignite innovation, and address the needs for social connection and learning in the new world of work.
Imperative is powered by its employee purpose profiling technology that enables the platform to accelerate trust between employees and enable everyone to serve as mentors for each other - reducing voluntary turnover by 35%.
Since its launch in 2020, large and quickly growing companies like Microsoft, Hasbro, Accolade, GSK, Boston Scientific, Airbnb, and Zillow have adopted the platform to break down barriers within their organizations and empower their employees to align their purpose with their daily work. Imperative is a B Corporation founded by workplace entrepreneur Aaron Hurst and funded by Voyager Capital and Court Lorenzini, founding CEO of DocuSign.
We believe that within five years, every company will require technology to enable enterprise-wide employee networks that uniquely address the growing need for well-being, connection, and career pathing.
Imperative was acquired by Chronus in 2024.
Investor
Jan 2018
Gaingels is a leading venture investment syndicate in support of and representing the LGBTQIA+ community and allies in the venture capital space. Gaingels also supports its companies with a diverse talent and capital pipeline and provides an internal diverse board member recruitment advisory to help bring more diversity and representation within private boards. Gaingels invests in companies with diverse/LGBTQIA+ founders and C-suite leaders at all stages of growth, as well as in other high-growth companies resolved on building more inclusive teams. Gaingels is an ardent supporter the Diversity Term Sheet Rider Initiative to increase access to venture funding events for non-traditional check writers, and regularly co-invests with select VC leads across a variety of sectors, from technology, to B2B, healthcare and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO. For more information visit www.gaingels.com.
VC Investor
Jan 2016
Avitus Orthopaedics was created out of a passion for solving unmet needs. We changed the game on bone and marrow harvesting. We then evolved with bone infection debridement; tackling pseudomembrane and biofilm debridement during PJI and osteomyelitis/tumor curettage. Most recently we have launched advances in percutaneous autogenous graft delivery.
We now can perform MIS Bone & Marrow Harvesting, MIS Debridement/Curettage and MIS Autograft Delivery.
Learn more about our products at our website.
VC Investor
Aug 2015
Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology.
Our 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivational content, we bring healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Our mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. We make it fun for patients to stay on top of their medications, help them address any medication challenges, and empower them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases.
Venture Investor
May 2015
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins focused on Empowered Patient Care. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs.
EchoMark is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels such that the site can be easily assessed for future complications. EchoSure is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to assess blood flow and morphology of vessels marked by the implanted EchoMark device.
For more information, please visit http://www.sonavex.com
Experience · 22 entries
All (22)
Investments (13)
Founder (2)
2025
Founder
Dec 2025
A network for entrepreneurs building in stealth.
Submit your information here so investors can find you:
harmonic.ai/get-discovered
Founder | Global Co-Investment Ecosystems
Jun 2025
Co-Invest with Top VCs is a multi-stage fund based in NewYork City. It backs sector-agnostic companies sourced from partner networks across the globe. The collective supports high-quality global founders and companies by co-investing alongside top VC firms, trusted accelerators and ecosystem partners. Its mission is to generate returns while shaping the ecosystem and representing a diverse group of investors within the capital stack of its portfolio companies
2024
Investor
Dec 2024
Hi! We’re Aavia, a daily app that helps you track & understand how your hormones impact your life. Ovarian hormones impact everything from quality of sleep and risk of injury to mood and sex drive. Our unique design and experience provides members with insights, predictions, and education into their hormone cycles to feel better, and supports doctors to provide more efficient care to reach faster diagnosis of hormone conditions.
Aavia was founded at MIT by a customer-obsessed MBA, an award-winning product designer, and a patent-owning electrical engineer, all energized by their mission to change the way that the world understands ovarian hormones thanks to their personal experiences. What began with our patented Smart Birth Control Pill Case evolved into an all-in-one app for hormone health insights for all people with ovaries.
We are backed by some of the most innovative consumer and health tech investors, founders, and advisors including 776, Asset Management Ventures, and more. Together, we are building a world-class product to impact the ovarian hormone health of generations to come.
Learn more on www.aavia.io, the Aavia app (available on iOS), Instagram @aavia.io, Twitter @aavia_io, and TikTok!
Investor
Apr 2024
Axiom Space is a human space exploration company, building era-defining space infrastructure and delivering technology-driven solutions that will empower civilization to transcend Earth. Beginning with Axiom Station, successor to the International Space Station, the company is pioneering a next-generation orbital settlement that will foster groundbreaking innovation and research in microgravity and drive the global space economy of tomorrow. Today, guided by the vision of leading humanitys expansion off planet, Axiom Space is the principal provider of commercial human spaceflight services and developer of advanced spacesuits for the Moon and beyond.
Connect with us:
instagram.com/axiom.space/
twitter.com/axiom_space
facebook.com/axiomspace/
youtube.com/axiomspace
Investor
Mar 2024
We are a team of engineers, scientists and doctors working at the intersection of AI, Physics and Biology to make the Star Trek MedBay a reality.
Show all 22 entries ↓
Investment activity
2014–2024 · 13 investments
Recent (last 2 years)Earlier
